118th Congress Health
S. 1218: Fair Prescription Drug Prices for Americans Act
Introduced
- Introduced (completed)
- Passed Senate (not reached)
- Passed House (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill caps the price of drugs and biologics at the average price among certain countries.
Specifically, the retail list price of a drug or biologic in the United States may not exceed the average retail list price among Canada, France, Germany, Italy, Japan, and the United Kingdom. The Department of Health and Human Services (HHS) must calculate the average price in these countries based on data that is submitted by manufacturers directly to HHS and on publicly filed materials from manufacturers.
Manufacturers who violate the bill's price cap are subject to civil penalties.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Who scored on this bill
No member has earned points from it yet.
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Joshua Hawley
- S. 5163: No Bonuses for Bad Service Act
- S. 3062: GUARD Act
- S. 2169: Rural Hospital Cybersecurity Enhancement Act
- S. 3490: National Historical Park and National Historic Landmark Establishment and Boundary Adjustments Act of 2025
- S. 1498: Halting Ownership and Non-Ethical Stock Transactions (HONEST) Act
- S. 1829: STOP CSAM Act of 2025
History
- Introduced in the Senate by Joshua Hawley.
Show the full action history (2 actions)
- Introduced in Senate
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.